Read as much as you want on BostonGlobe.com, anywhere and anytime, for just 99¢.

Thousands of J&J’s Adept hip implants recalled

TRENTON, N.J. — Johnson & Johnson has again recalled thousands of its hip implants, 2½ years after the problem-plagued health care giant issued a recall of two other types of its artificial hips.

Spokeswomen for J&J’s DePuy Orthopaedics unit said Thursday that the company recalled the ‘‘Adept’’ brand all-metal total hip replacement system starting last month because a higher-than-expected percentage of them had to be replaced. Such replacements, called revision surgeries, usually are needed when an artificial joint starts causing pain, difficulty walking or other problems.

Continue reading below

The recall involves only the top part of the hip replacement system, the ball at the top of the thigh bone that fits into the hip’s socket.

New Brunswick, N.J.-based J&J said it has recalled all 7,500 Adept implants shipped worldwide between 2004 and September 2011. That is when it sold the product back to the company that had developed Adept and had sold the rights to it to the DePuy business in 2009.

According to J&J, the implants were sold in Germany and 20 other countries, but not in the United States.

J&J said it notified surgeons and hospitals about the recall on Jan. 14 after reviewing data from national registries on joint replacements in two countries. A registry in the United Kingdom found that 12.1 percent of patients needed their implants replaced within seven years, while a registry in Australia found 7.1 percent of patients needed replacements within three years.

The DePuy spokeswomen did not know how many of the recalled implants were implanted in patients. Any who have the implants and are having problems with them should contact their doctor.

The recall was reported Thursday by the German newspaper Handelsblatt.

J&J noted the recall does not involve a product called Adept Hip Resurfacing Femoral Components.

J&J, the world’s biggest provider of health care products, has issued more than 30 product recalls since 2009. Shares rose 15 cents to $75.81.

Loading comments...
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com